TrialBritish journal of clinical pharmacology2017

Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660).

Bruce E Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.